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Background: A nursing shortage in the United States has resulted in increased workloads, potentially affecting the
quality of care. This situation is particularly concerning in long-term care (LTC) facilities, where residents are older,
frailer, and may be receiving multiple medications for comorbidities, thus requiring a greater commitment of nurse
time. We conducted a survey of LTC nurses to determine how much of their time each week is spent managing
newly started and stable warfarin-treated residents.
Methods: Forty LTC nurses validated the questionnaire to determine what protocols/procedures are involved in
warfarin management. Twenty LTC nurses completed the survey, quantifying the time they spend on procedures
related to warfarin management, and how often they performed each procedure for each resident each week.
Results: The nurses reported that 26% of their residents were receiving warfarin; the majority (approximately 75%)
of these residents began warfarin after admission to the facility. On average, the nurses spent 4.6 hours per week
for treatment procedures and monitoring patients initiating warfarin therapy and 2.35 hours per week for each
resident who was stable on warfarin therapy on admission. Overall, to care for an average number of newly initiated
and stable warfarin patients in a medium-size LTC facility, staff nurses are estimated to spend 68 hours per week.
Study limitations include the potential for bias because of the small sample size, representativeness of the sample, and
the possibility of inaccuracies in respondents’ self-reported time estimation of warfarin-related procedures.
Conclusions: In the context of a well-documented and expanding nursing shortage in the United States, the
substantial use of time and resources necessary to initiate, monitor, and manage warfarin treatment in elderly LTC
patients is of concern. Until the problem of understaffing is resolved, implementation of therapies that are simpler and
require less nursing time—e.g. the use of new oral anticoagulants in the place of warfarin—may be a way to free up
nursing time for other essential care tasks.
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The state of the nursing profession in the United States
today
As more people live to older ages, there is an increasing
need for healthcare services. Registered nurses (RNs)
comprise the largest and most rapidly expanding seg-
ment of the healthcare workforce. According to the
Bureau of Labor Statistics, unfilled positions for RNs are
projected to reach 1.2 million by 2020 [1].* Correspondence: apatel15@its.jnj.com
Janssen Scientific Affairs, LLC, 1000 Route 202, Raritan, NJ 08869, USA
© 2015 Patel and Nelson; licensee BioMed Ce
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.A shrinking economy appears to have eased the
nursing shortage, but with an anticipated 32 million
Americans gaining access to healthcare services as a
result of the Patient Protection and Affordable Care Act,
the need for nurses will become even more pressing and
is projected to outstrip nurse availability [2,3].How the shortage of nurses affects patient care
A 2002 survey reported in the New England Journal of
Medicine found that 53% of physicians and 65% of the
public believe that a shortage of nurses increases the risk
of medical errors [4]. Research on hospital-acquiredntral. This is an Open Access article distributed under the terms of the Creative
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merely one patient can result in higher rates of urinary
tract and surgical-site infections [5]. Survey data from
40,000 RNs has also shown that, when linked with pa-
tient mortality data, increasing the number of patients
per hospital nurse from four to eight results in a 1.26-
fold greater risk of in-hospital mortality [6]. In a study
that analyzed the records of approximately 198,000
patients across 43 care units, the mortality risk was up
to 4% higher in units that were below target staffing
levels than in fully staffed units [7].
With a growing elderly population, the shortage of
nurses is expected to be particularly acute in long-term
care (LTC) facilities. Elderly LTC residents require close
attention and may have multiple conditions (e.g. dia-
betes, heart failure, hypertension, gastrointestinal or uro-
logic disorders, and chronic pain) for which they receive
numerous chronic medications, many of which must be
administered multiple times throughout the day, impos-
ing considerable demands on nurses’ time.
Warfarin in long-term care
The anticoagulant warfarin is a prime example of a chal-
lenging and difficult-to-manage drug that is commonly
used in the LTC setting. Warfarin is generally used to
treat residents with procoagulant and cardiovascular
conditions, including nonvalvular atrial fibrillation, the
prevalence of which is reported to range from 7.5–17%
among LTC residents [8-11]. Although efficacious as an
anticoagulant, patients on warfarin require close moni-
toring to maintain optimal coagulation levels: if under-
coagulated, the patient is at risk of a thromboembolic
event; if over-coagulated, there is a risk of bleeding com-
plications. In addition, warfarin has a narrow therapeutic
window and interacts with several common drugs (e.g.
lipid-lowering agents, antihypertensives, gastrointestinal
drugs, analgesics, and anti-infectives) as well as with
food and alcohol. Therefore, patients treated with war-
farin require regular monitoring of international normal-
ized ratio (INR) values to ensure therapeutic efficacy and
avoid potentially life-threatening adverse events. In the
LTC setting, frequent INR monitoring as well as other
patient factors, such as advanced age, comorbid condi-
tions, and polypharmacy, make the management of war-
farin particularly time consuming.
There is limited evidence in the literature examining the
amount of time RNs and licensed practical nurses (LPNs)
spend managing LTC residents newly initiated or stable
on warfarin therapy. With healthcare resources scarce,
analysis of the time involved in LTC patient management
can inform decisions on the allocation of healthcare re-
sources to ensure that they are efficiently utilized.
We undertook a primary semi-quantitative web-based
survey of LTC nurses who were responsible for the careof LTC residents who received warfarin. Our objectives
were to determine the specific nursing tasks related to
warfarin therapy and estimate the time requirements for
warfarin management, treatment initiation, and monitoring.
Methods
Before constructing our survey, we conducted a litera-
ture search of peer-reviewed articles specific to warfarin
management to develop a comprehensive list of activities
performed by nurses during the course of managing new
and stable warfarin residents in LTC facilities. We vali-
dated the accuracy of our findings by surveying a group
of registered or licensed LTC nurses who were selected
from a proprietary database including nurses throughout
the United States. Nurses were contacted directly by
e-mail, and respondents were screened to ensure that
licensure requirements were met. Nurses who responded
to the survey helped to refine the list of tasks and were
also given the opportunity to propose adding or deleting
tasks from the list. Based on nurses’ feedback, we cre-
ated a follow-up survey (Additional file 1), in which 20
nurses (15 RNs, five LPNs) in LTC facilities were asked
to (1) confirm these steps and procedures with respect
to their individual responsibilities, and (2) provide an
estimate of total completion times for each task, and
report how often they perform each task each week for
each resident receiving warfarin. For residents newly
initiated on warfarin therapy, survey respondents were
asked to report three categories of tasks: initiation (ac-
tivities or tasks to start patients on warfarin), monitoring
(INR testing and monitoring for bruising), and manage-
ment (activities or tasks related to monitoring docu-
mentation, patient education, and physician/pharmacist
consultation). For stable warfarin residents, only moni-
toring and management had to be reported. Participants
were required to spend at least 50% of their daily time
in direct patient care, per their assessment, and to have
previous experience managing warfarin treatment. Re-
spondents were asked to only estimate and self-report
time that was actively spent documenting/performing
warfarin-related procedures or educating residents (e.g.
dietary consultations to discuss any potential drug-food
interactions, medication profiles to account for potential
drug-drug interactions, health education, and the need for
ongoing monitoring). This time was self-reported and
estimated. Rather than report the number of beds in their
facilities, this was reported as a range: small (1–99 beds),
medium (100–199 beds), and large (≥200 beds). To
minimize geographical bias, only two nurses per state were
permitted to participate in the survey.
On the basis of the estimates provided by the LTC
nurses participating in the survey, the average time esti-
mated per task is calculated as the number of times the
task is performed per resident multiplied by the amount
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time in residents newly initiated on warfarin therapy and
stable warfarin residents is then derived by summing the
average time per task over all the tasks per week. The
total number of nursing hours was estimated based on
the average percentage of warfarin residents (as a frac-
tion of all residents in the facility) assuming a medium-
size (100–199 beds) LTC facility. Because the percentage
of newly initiated and stable warfarin patients was not
reported, our analysis assumes that the majority of resi-
dents in the LTC facility were stable warfarin patients,
providing for a more conservative estimate. The average
time nurses estimated per week for newly initiated or
stable warfarin residents within a medium-size facility is
calculated as the number of warfarin residents multi-
plied by the amount of time per warfarin resident. The
total number of hours LTC nurses spent managing resi-
dents receiving warfarin is derived by summing the total
number of hours for both newly initiated and stable
warfarin residents.Table 1 Median completion time spent on warfarin
treatment initiation protocols/procedures
Procedure Completion time per
patient (minutes)
Baseline INR 20




CBC at initiation of warfarin therapy 15
PRN order for INR levels when
complications are suspected
15
CBC= complete blood count; INR = international normalized ratio; PRN= pro re nata
(as needed); PT = prothrombin time.Results
Forty qualified respondents validated and revised the list
of procedures and other steps incorporated in the quan-
titative survey (30 RNs, 10 LPNs), while 20 were in-
volved in the confirmation of these tasks and follow-up
time-estimation survey (15 RNs, five LPNs). Because two
surveys were sent, the respondents who participated in
the first survey were not the same as those who partici-
pated in the second. However, all survey respondents
took part in the validation and confirmation of the tasks
included in the second questionnaire (N = 40). All
respondents were nurses in LTC facilities and spent at
least 50% of their time each day in direct patient care.
They worked in a mix of nursing care facilities: skilled
nursing facility (n = 39; inpatient post-acute care [12]);
intermediate-care facility (n = 4; provides level of nursing
care higher than the general ward without intensive care
[13]), and a subacute facility (n = 1; inpatient intensive
rehabilitative medical care between skilled nursing and
acute hospital care [14]). (Some of the 40 institutions
provided mixed services and were counted twice.) Of
these facilities, 38% were categorized as small (1–99
beds), 43% as medium (100–199 beds), and 20% as large
(≥200 beds). The majority of LTC facilities (87.5%) were
owned and operated by the state, county, or local
government.
Respondents estimated from their experience that 26%
of the residents in their units of their LTC facilities were
receiving warfarin. Of these patients, one-quarter were
already receiving warfarin upon admission to the facility;
three-quarters were initiated on warfarin therapy during
their stay.Protocols and procedures for newly initiated warfarin
residents
Median completion time per patient for procedures re-
lated to warfarin initiation is shown in Table 1. Consid-
erable time is spent on dietary consultations to discuss
any potential drug-food interactions, medication profiles
to account for potential drug–drug interactions, and
patient education regarding these concerns and the need
for ongoing monitoring of anticoagulation levels. The
median time spent on protocols specific to monitoring
newly initiated residents is shown in Table 2.
Protocols and procedures for stable warfarin residents
Median time spent per patient for procedures related to
monitoring stable warfarin residents is shown in Table 3.
On average, each task takes nurses between 5 and
10 minutes, with monitoring and documenting labora-
tory values requiring the most time. Thus, LTC nurses
spend just over 1 hour per week performing the tasks
required for monitoring anticoagulation levels in resi-
dents who are stable on warfarin therapy.
Non-monitoring management tasks for all warfarin
residents
All residents receiving warfarin require an investment of
time that is not related to monitoring, as shown in
Table 4. Each of these management tasks takes relatively
little time—between 5 and 12 minutes—with documen-
tation requiring the most time. Nevertheless, in the
aggregate, these tasks require an average of 1.25 hours
per week per warfarin resident.
Estimated nursing time per week for newly initiated and
stable warfarin residents
Respondents reported spending 2.35 hours per week for
each stable resident and 5.9 hours per week for each newly
initiated warfarin patient. For stable patients, the time spent
included 1.05 nursing hours per week for monitoring and
Table 2 Median time spent on protocols/procedures
related to monitoring residents newly initiated on
warfarin therapy








values on the anticoagulation
care/flow sheet
5 2





to monitor for signs and
symptoms of bleeding
8 7
INR = international normalized ratio; PT = prothrombin time.
Table 4 Median time spent on protocols/procedures not







precautions on the patient’s
care plan
12 1
Order next INR test 5 1
Consult referring physician
for all coagulation test
results out of range
5 1
Adjust the warfarin dose when












Provide routine education 5 3
Make CNAs aware of warfarin
residents and care plan
5 3
CNA = Certified Nursing Assistant; INR = international normalized ratio.
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ated patients, 2.4 nursing hours per week were required for
warfarin initiation, 2.2 hours per week for monitoring, and
1.3 hours per week for management.
Based on a hypothetical medium-sized LTC facility (100
beds), when both newly initiated (n = 2) and stable war-
farin residents (n = 24) were taken into account, including
all the time devoted to warfarin initiation, monitoring, and
management tasks, LTC nurses reported an average of
68 hours per week required for warfarin-related tasks,
11.8 hours per week for newly initiated, and 56.4 hours
per week for residents already stable on warfarin therapy.
Underestimation of nursing time
Nurses were asked to subjectively estimate time spent
managing a single warfarin patient and all of their warfarin
patients. This subjective assessment was asked before the
quantitative survey questions that determined the itemized
time spent on warfarin management, to reduce potential
bias. Of all respondents, 43% estimated that they spent up
to 30 minutes per week managing a single warfarinTable 3 Median time spent on protocols/procedures
















to monitor for signs/symptoms
of bleeding
5 3
INR = international normalized ratio.resident; only 10% believed that they spent 46–60 minutes
per week. Approximately half of respondents (48%)
estimated that they spent more than 3 hours per week
managing all of their warfarin-treated residents; the
remaining 52% believed that they spent 3 hours or less.
Discussion
To our knowledge, this study is the first to assess the
time taken for nurses to monitor and manage warfarin
therapy in warfarin patients in an LTC setting. Based on
the self-time estimation responses of 15 RNs and five
LPNs, our study showed that nurses in LTC facilities in
the United States spent an average of 2.4 hours per week
(2.4 hours per patient) performing warfarin initiation
procedures, 1.05–2.4 hours per week (25–28 minutes
per patient) performing warfarin monitoring tasks, and
1.3 hours per week (57 minutes per patient) performing
procedures related to warfarin management. A survey-
based study by Andersson and colleagues showed similar
findings with regard to the time taken by nurses to per-
form warfarin monitoring procedures in a primary
healthcare setting in Sweden [15]. Their study reported
an average of 21.4 minutes per patient to perform INR
monitoring procedures (preparation, direct patient con-
tact, and follow-up). Although the time taken for nurses
to perform warfarin monitoring procedures are similar
between the two studies, the study by Andersson only
estimated the time taken to perform INR monitoring pro-
cedures; it did not take into account the time spent for
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was conducted in a primary healthcare setting and most
likely included a more diverse patient demographic, includ-
ing younger and potentially healthier individuals. Thus,
while the results of our study may not be entirely translat-
able, there is previous work that utilizes self-reported esti-
mates or modeled estimates of resource utilization to
determine the time required to complete specific tasks [16].
Although the LTC setting would seem to be ideal for
warfarin therapy, because laboratory monitoring, com-
pliance, dose adjustment, and drug-drug interactions can
be controlled for, our study found that the estimated
time taken by nurses to perform procedures involved in
such management requires substantial resources (up to
68 nursing hours per week when both newly initiated
and stable warfarin patients are taken into account).
This finding is in stark contrast to the subjective assess-
ment provided by the nurses, who reported an average
of 3 hours each week to manage all of their warfarin res-
idents. This discrepancy in time utilization is likely due
to the repetitive and routine nature of the procedures,
which may result in a tendency to underestimate the
time taken to complete each task. Additionally, when
asked to estimate the time taken to perform these proce-
dures, respondents may have based their responses on the
time taken to monitor and manage stable warfarin resi-
dents, which may have considerably reduced the subject-
ive time estimate, as initiation procedures were by far the
most time-consuming based on the quantitative time esti-
mates. It is also possible that the reported time could be
inaccurate if nurses estimated separate amounts of time
for discrete tasks that were consolidated and performed at
the same time, or conversely, if they suddenly needed to
tend to another patient and reported the time altogether
as one warfarin-related task. Furthermore, nursing leaders
responsible for time allocation may overlook opportunities
to improve warfarin management processes if actual
procedure times are unintentionally minimized.
This study was subject to several limitations, including
the potential for bias due to a small sample size, represen-
tativeness of the sample, and the possibility of inaccuracies
in self-time estimation by respondents because of human
error or overlap of warfarin-related tasks with routine
physical assessments. Because our study methods were
predicated on a market-based research model using a
survey design, details on recruitment, respondent demo-
graphic characteristics (e.g. years of experience), or institu-
tion (e.g. number of beds) were not collected. Based on
our calculations, the use of a hypothetical medium-sized
LTC facility (100–199 beds) may have led to potential
over- or under-estimation of the weekly and total time
taken by nurses to perform warfarin-related procedures.
In addition, our study was not powered to determine dif-
ferences in the times taken to perform warfarin-relatedprocedures based on nurse designations and type of LTC.
Because the two nurse populations surveyed were different
(15 RNs, five LPNs), a statistical analysis of the differences
in time estimations may not have been optimal. Because
our study only captured the time spent by nurses monitor-
ing and managing warfarin patients, additional work that
was carried out by other types of personnel (e.g. laboratory
staff and assistant nurses) and other factors not related to
time estimation (e.g. quality of care) have not been
accounted for. Furthermore, there is a potential double-
counting of facilities that provide more than one of the
services outlined in the types of facilities that were consid-
ered in this study. Therefore, the results are to be regarded
as a conservative estimate of the time resources required
for carrying out warfarin-related procedures in LTC facil-
ities in the United States. Additional prospective studies
are needed to examine differences in the time taken to
perform warfarin-related procedures based on nurse
designation and type of LTC.
Conclusions
In the context of a well-documented and expanding
nursing shortage in the United States, the substantial
use of time and resources necessary to initiate, monitor,
and manage warfarin treatment in elderly LTC patients
is of concern. As a result of insufficient numbers of
nurses being trained to care for a growing population of
older patients, even (or perhaps especially) the most
committed nurses are becoming frustrated, demoralized,
and burned out, potentially further reducing the ranks of
qualified professionals and posing an increased threat to
optimal anticoagulation management [17,18]. This is
particularly worrisome in the LTC setting, where the
growing disparity between the increasing number of
elderly individuals and the decreasing number of those
who are charged with caring for them threatens to put
frail and ill individuals at risk. Until the problem of under-
staffing is resolved, it would seem reasonable to maximize
nurse efficiencies by making it possible for fewer nurses to
provide optimal care. One solution, among others, might
be to replace therapies that place a substantial burden on
nurses with more efficient care models. Newer oral antico-
agulants are available that have been shown to be safe and
effective [19-21], as well as cost-effective, in older patients
[22]. These agents have stable pharmacokinetics and fixed
dosing. As a result, although regular assessments to moni-
tor for symptoms of gastrointestinal or other bleeding are
still necessary with the newer, target-specific oral anti-
coagulants, the routine INR monitoring, documentation
of laboratory test results, dietary education, and dosing
changes that are required with warfarin treatment are no
longer needed with the newer agents. Adopting these
newer anticoagulants could free up LTC nurses for other
pressing patient responsibilities.
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